The insider sales are too small relative to market cap to warrant a bearish read. The CMO's sale was paired with a derivative exercise, typical of tax- or liquidity-driven planning. Monitor for any larger insider sales or a cluster exceeding 0.5% of market cap before adjusting stance.
Price Chart
Executive Summary
Two insiders at Monte Rosa Therapeutics sold a total of $364K in open-market sales over a 7-day window, including the Chief Medical Officer and a Director. The sales are modest relative to the $2.0B market cap (0.02%), and the CMO's sale was paired with a derivative exercise, suggesting a liquidity-driven transaction rather than a bearish signal. The cluster is amplified by the presence of a non-cash director grant on the same dates, but the dollar value is too small to be material.
Key Financial Metrics
Key Facts
- Total insider sales of $364K over 7 days, representing 0.02% of market cap
- CMO Janku Filip sold 5,407 shares at $24.50 ($132K) on June 30, paired with derivative exercises
- Director Anthony Manning sold 10,000 shares at $23.11 ($231K) on June 29
- Director Ali Behbahani received 1,015,000 shares in non-cash transactions (no economic signal)
- Sales are well below the 0.1% materiality threshold for a $2.0B company
Financial Impact
Total insider sales of $364K, or 0.02% of the $2.0B market cap
Risk Factors
- Insider sales could accelerate if the stock continues to rise, but current levels are immaterial
- No recent company filings (earnings, pipeline updates) to contextualize the sales
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-GLUE-1783375269563 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 1, 2026 25d ago | 8-K | $11.26 | awaiting T+60 | — | $10.48 (−6.93%) |
Sep 30, 2026 26d ago | Press Release | $11.26 | awaiting T+60 | — | $10.48 (−6.93%) |
Aug 6, 2026 11w ago | 8-K | $15.71 | awaiting T+60 | — | $10.48 (−33.29%) |
Jul 17, 2026 14w ago | Insider Cluster | $23.48 $9.89 | ▼ −57.88% | ▼ −62.72% | $10.48 (−55.37%) |
Jul 7, 2026 15w ago | Insider Cluster | $24.06 $11.93 | ▼ −50.42% | ▼ −52.73% | $10.48 (−56.44%) |
Jul 1, 2026 16w ago | Insider Cluster | $24.21 $11.72 | ▼ −51.59% | ▼ −54.60% | $10.48 (−56.71%) |
Jul 1, 2026 16w ago | Insider Cluster | $24.21 $11.72 | ▼ −51.59% | ▼ −54.60% | $10.48 (−56.71%) |
Jun 29, 2026 17w ago | 144 | $24.20 $11.89 | ▼ −50.87% | ▼ −54.43% | $10.48 (−56.69%) |
Jun 25, 2026 17w ago | Insider Cluster | $22.29 $12.60 | ▼ −43.47% | ▼ −49.56% | $10.48 (−52.98%) |
Jun 2, 2026 20w ago | Insider Cluster | $17.59 $14.32 | ▼ −18.59% | ▼ −21.09% | $10.48 (−40.42%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers